TG
HZNP

TCW Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

TCW Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-62,721
Closed -$1.01M – 661
2016
Q4 		$1.01M Sell
62,721
-51,235
-45% -$929K 0.01% 492
2016
Q3 		$2.07M Sell
113,956
-4,440
-4% -$86.7K 0.02% 326
2016
Q2 		$1.95M Sell
118,396
-45,107
-28% -$730K 0.01% 330
2016
Q1 		$2.71M Buy
163,503
+5,203
+3% +$91K 0.02% 276
2015
Q4 		$3.43M Buy
158,300
+100,333
+173% +$1.95M 0.02% 247
2015
Q3 		$1.15M Buy
+57,967
New +$1.83M 0.01% 475

Other funds holding HZNP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

TCW Group's HZNP Position: Q1 2017 in Review

TCW Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2017, closing a stake of 62,721 shares — an estimated $1.01M sold.

TCW Group first reported a position in HZNP in Q3 2015 and held it in 6 quarters. The position peaked at $3.43M in Q4 2015. 210 funds tracked by Wall St. Rank hold HZNP as of Q1 2017.

  • TCW Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2017 after selling out during the quarter.
  • TCW Group sold 62,721 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2017, an estimated $1.01M.
  • TCW Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 6 quarters.
  • TCW Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.43M in Q4 2015.
  • 210 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2017.

Based on TCW Group's 13F filing for Q1 2017, filed 12 May 2017.